What is NovoCure's operating cash flow?

NovoCure (NVCR) reported operating cash flow of -$13.52M in Q1 2026.

How has NovoCure's operating cash flow changed year-over-year?

NovoCure's operating cash flow increased by 62.1% year-over-year, from -$35.67M to -$13.52M.

What is the long-term trend for NovoCure's operating cash flow?

Over 3 years (2021 to 2025), NovoCure's operating cash flow has grown at a -16.0% compound annual growth rate (CAGR), from $82.76M to -$49.03M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

NovoCure NVCR Operating Cash Flow

Operating Cash Flow at other companies

Boston ScientificBSX

$348M-35.7%

MedtronicMDT

$2.57B+1.8%

Iovance Biotherapeutics, Inc.IOVA

-$72.07M+30.5%

Nuvation BioNUVB

$5.07M+112%

Vir Biotechnology, Inc.VIR

-$132.39M-69.5%

ArriVent BioPharma, Inc.AVBP

-$41.89M+38.4%

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.64B-36.7%

Enterprise value$1.59B-36.3%

P/S2.4×-1.7×

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's operating cash flow?: NovoCure (NVCR) reported operating cash flow of -$13.52M in Q1 2026.
How has NovoCure's operating cash flow changed year-over-year?: NovoCure's operating cash flow increased by 62.1% year-over-year, from -$35.67M to -$13.52M.
What is the long-term trend for NovoCure's operating cash flow?: Over 3 years (2021 to 2025), NovoCure's operating cash flow has grown at a -16.0% compound annual growth rate (CAGR), from $82.76M to -$49.03M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.